Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ross St C Barnetson

Showing results (11-20 of 13) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 13 results.
Oncotarget|July 19, 2012
Destroying c-jun Messenger: new insights into biological mechanisms of DNAzyme functionLevon M Khachigian, Hong Cai, Fergal J Moloney, et al.
Science Translational Medicine|June 23, 2012
DNAzyme targeting c-jun suppresses skin cancer growthHong Cai, Fernando S Santiago, Leonel Prado-Lourenco, et al.
Lancet (London, England)|May 11, 2013
Safety and tolerability of an intratumorally injected DNAzyme, Dz13, in patients with nodular basal-cell carcinoma: a phase 1 first-in-human trial (DISCOVER)Eun-Ae Cho, Fergal J Moloney, Hong Cai, et al.
Pageof 2

Showing results (11-20 of 13) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 13 results.
Oncotarget|July 19, 2012
Destroying c-jun Messenger: new insights into biological mechanisms of DNAzyme functionLevon M Khachigian, Hong Cai, Fergal J Moloney, et al.
Science Translational Medicine|June 23, 2012
DNAzyme targeting c-jun suppresses skin cancer growthHong Cai, Fernando S Santiago, Leonel Prado-Lourenco, et al.
Lancet (London, England)|May 11, 2013
Safety and tolerability of an intratumorally injected DNAzyme, Dz13, in patients with nodular basal-cell carcinoma: a phase 1 first-in-human trial (DISCOVER)Eun-Ae Cho, Fergal J Moloney, Hong Cai, et al.
Pageof 2